It’s starting to become clear that there won’t be a cardiologist in charge of the FDA. Duke’s Rob Califf, the last of two cardiologists rumored to be in the running for FDA commissioner, is no longer a contender for the influential position, according to The Washington Post and The Scientist. (The Cleveland Clinic’s Steve Nissen had earlier been viewed as another prime candidate.)
In the Washington Post item, Al Kamen reports that the two finalists are now Joshaua Sharfstein, who is the Baltimore health commissioner, and new entry Margaret Hamburg, an assistant secrety of HHS in the Clinton administration. The Scientist notes that Califf’s candidacy was derailed after Tom Daschle’s candidacy for HHS secretary was itself derailed.
Speak Your Mind